Common Contracts
2 similar Subordinated Convertible Promissory Note contracts by AEON Biopharma, Inc.
AEON BIOPHARMA, INC. AMENDMENT TO SUBORDINATED CONVERTIBLE PROMISSORY NOTESubordinated Convertible Promissory Note • October 4th, 2021 • AEON Biopharma, Inc. • Pharmaceutical preparations
This Amendment (this “Amendment”) to the Subordinated Convertible Promissory Note, as defined below, is made as of May 10, 2021 (the “Effective Date”), by and between AEON Biopharma, Inc., a Delaware corporation (the “Company”), and Daewoong Pharmaceutical Co., Ltd., a company organized and existing under the laws of the Republic of Korea (the “Holder”). Capitalized terms used but not otherwise defined herein shall have the same meanings as set forth in the Note Purchase Agreement, as defined below, or the Original Note, as applicable.
AEON BIOPHARMA, INC. AMENDMENT TO SUBORDINATED CONVERTIBLE PROMISSORY NOTESubordinated Convertible Promissory Note • October 4th, 2021 • AEON Biopharma, Inc. • Pharmaceutical preparations
This Amendment (this “Amendment”) to the Subordinated Convertible Promissory Note, as defined below, is made as of (the “Effective Date”), by and between AEON Biopharma, Inc., a Delaware corporation (the “Company”), and Daewoong Pharmaceutical Co., Ltd., a company organized and existing under the laws of the Republic of Korea (the “Holder”). Capitalized terms used but not otherwise defined herein shall have the same meanings as set forth in the Note Purchase Agreement, as defined below, or the Original Note, as applicable.
